LE VALPROMIDE (DEPAMIDE®) DANS LE TRAITEMENT D'ETATS PSYCHOTIQUES AIGUS. UNE ETUDE CLINIQUE OUVERTE

Translated title of the contribution: Valpromide (Depamide®) in the treatment of acute psychotic states: An open clinical study

A. C. Altamura, R. Basile, M. Mauri, C. L. Cazzullo

Research output: Contribution to journalArticlepeer-review

Abstract

In an open clinical study on the effect of Depamide in acute psychosis, 59 schizophrenic and 23 manic hospitalized patients were tested. They were divided in two groups: in group A, Depamide was administered only after an initial period of treatment with haloperidol or chlorpromazine; in group B instead, Depamide was added from the beginning of the neuroleptic treatment. The results show that the association of Depamide with neuroleptics leads to a reduction of agitation and of the hospitalization period, whereas it ameliorates the adaptation of the patients to the therapeutic milieu.

Translated title of the contributionValpromide (Depamide®) in the treatment of acute psychotic states: An open clinical study
Original languageFrench
Pages (from-to)297-304
Number of pages8
JournalActa Psychiatrica Belgica
Volume86
Issue number3
Publication statusPublished - 1986

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Valpromide (Depamide®) in the treatment of acute psychotic states: An open clinical study'. Together they form a unique fingerprint.

Cite this